https://de.marketscreener.com/kurs/aktie/HORIZON-THERAPEUTICS-PUBL-18100076/news/Health-Canada-genehmigt-UPLIZNA-Inebilizumab-zur-Injektion-von-Horizon-Therapeutics-plc-fur-die-45757879/?utm_source=telegram&utm_medium=social&utm_campaign=share